Literature DB >> 11876641

Diverse stability and catalytic properties of human tryptase alpha and beta isoforms are mediated by residue differences at the S1 pocket.

Trevor Selwood1, Zhi-Mei Wang, Darrell R McCaslin, Norman M Schechter.   

Abstract

Recombinant human tryptases (rHTs) corresponding to alpha and beta isoforms were characterized. rHTbeta was similar to tryptase isolated from skin (HST); it was a tetramer, hydrolyzed model substrates efficiently, and was functionally unstable when incubated under physiological conditions. Activity was lost rapidly (t(1/2) approximately 1 min) by a reversible process similar to that observed for the spontaneous inactivation of HST. Circular dichroism (CD) and intrinsic fluorescence emission (IFE) spectra of active rHTbeta corresponded to those of active HST and upon spontaneous inactivation IFE decreased in parallel to activity loss. rHTalpha differed from HST in catalytic ability and stability. rHTalpha did not react with model substrates, an active site titrant, or a competitive inhibitor of HST/rHTbeta. IFE and CD spectra were similar to those of the active and not the spontaneously inactivated form of HST. Under physiological conditions, rHTalpha IFE decreased at a rate 900-fold slower than that observed for HST, and rHTalpha remained tetrameric when examined by size exclusion chromatography at physiological salt concentration. Thus, rHTalpha is a stable "inactive" form of HT. Three active site variants of rHTalpha, K192Q, D216G, and K192Q-D216G were characterized. Residues 192 and 216 (chymotrypsinogen numbers for residues 191 and 215 of rHTalpha) lie at the entrance to the primary specificity (S1) pocket, and the mutations converted them to the residues of HTbeta. While K192Q displayed the same properties as rHTalpha, the catalytic and stability characteristics of D216G and K192Q-D216G progressively approached those of HST. Thus, the contrasting stability/activity properties of rHTalpha and rHTbeta are largely related to differences at the S1 pocket. On the basis of the properties of the variants, we suggest that the side chain of Asp216 is blocking and stabilizing the S1 pocket and that this stabilization is sufficient to prevent spontaneous inactivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876641     DOI: 10.1021/bi015662v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.

Authors:  Nicole E Jackson; Hong-Wei Wang; Katherine J Bryant; H Patrick McNeil; Ahsan Husain; Ke Liu; Nicodemus Tedla; Paul S Thomas; Garry C King; Anusha Hettiaratchi; Jennifer Cairns; John E Hunt
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

2.  Allosteric control of βII-tryptase by a redox active disulfide bond.

Authors:  Kristina M Cook; H Patrick McNeil; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

3.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

4.  Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C.

Authors:  Quang T Le; Hae-Ki Min; Han-Zhang Xia; Yoshihiro Fukuoka; Nobuhiko Katunuma; Lawrence B Schwartz
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

5.  Mast cell alpha and beta tryptases changed rapidly during primate speciation and evolved from gamma-like transmembrane peptidases in ancestral vertebrates.

Authors:  Neil N Trivedi; Qiao Tong; Kavita Raman; Vikash J Bhagwandin; George H Caughey
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

6.  Enhanced protein expression in the baculovirus/insect cell system using engineered SUMO fusions.

Authors:  Li Liu; Joshua Spurrier; Tauseef R Butt; James E Strickler
Journal:  Protein Expr Purif       Date:  2008-08-05       Impact factor: 1.650

7.  Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.

Authors:  Neil N Trivedi; Bani Tamraz; Catherine Chu; Pui-Yan Kwok; George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2009-09-12       Impact factor: 10.793

8.  Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.

Authors:  Quang T Le; Jonathan J Lyons; Andrea N Naranjo; Ana Olivera; Robert A Lazarus; Dean D Metcalfe; Joshua D Milner; Lawrence B Schwartz
Journal:  J Exp Med       Date:  2019-07-23       Impact factor: 14.307

Review 9.  Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.

Authors:  Bettina Sprinzl; Georg Greiner; Goekhan Uyanik; Michel Arock; Torsten Haferlach; Wolfgang R Sperr; Peter Valent; Gregor Hoermann
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.